Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Axsome
Fierce Biotech
FDA refuses Axsome filing for former Pfizer fibromyalgia asset
Axsome is plotting another phase 3 trial to make up for a study that the FDA deemed inadequate and not well-controlled.
Darren Incorvaia
Jun 9, 2025 12:27pm
Axsome will begin trial this year in MDD with daytime sleepiness
Apr 1, 2025 4:40pm
Axsome's Sunosi scores in phase 3 ADHD trial
Mar 25, 2025 11:46am
Teva agrees with Axsome to keep generic off market until 2038
Feb 10, 2025 11:28am
Axsome secures hard-fought FDA nod for migraine drug Symbravo
Jan 31, 2025 8:18am
After trial win, Axsome eyes FDA filing for narcolepsy hopeful
Nov 27, 2024 9:46am
